Annual Scientific Meeting
International Speakers
Roger Li
Dr Roger Li is a urologic oncologist at Moffitt Cancer Center whose practice focuses on the treatment of bladder, upper tract urothelial and prostate cancers. Dr Li’s research interest includes the molecular characterization of urothelial malignancies as well as developing novel immunotherapeutic strategies. Dr Li’s work has been instrumental in the development of clinical trials in the BCG-unresponsive space. His research is funded by the DoD, ACS, and BCAN. He has authored over 100 peer-reviewed manuscripts and serves as reviewer for many international urologic journals.
Tian Zhang
Dr. Zhang received her MD from the Harvard-MIT Health Sciences and Technology (HST) program and completed post-graduate training at Duke University, where she remained on faculty until 2021. She is currently Associate Director of Clinical Research in the Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center. Clinically she specializes in genitourinary malignancies and is a clinical researcher focused on improving novel therapies and biomarkers for patients with renal, prostate, and urothelial cancers. She serves as co-chair of the NCI GU Steering Committee Renal Task Force and participates on national committees for ASCO, SITC, CAHON, and KCA.
Alison Tree
Alison Tree was appointed as a consultant clinical oncologist at the Royal Marsden hospital in 2014, specialising in urological malignancies. She is the GU editor for the International Journal of Radiation Oncology Biology and Physics, the lead journal globally dedicated to radiation-related research. She is chair of the MR Linac Consortium Steering Committee and teaches on several ESTRO and ASTRO courses. She is Chief Investigator of the TRAP, DELINEATE, HERMES, DESTINATION 1 and 2 and PACE C trials. She is the joint lead of the Cancer Research UK Radiation Research Centre of Excellence at The ICR/Royal Marsden. Her research has received funding from Prostate Cancer UK, Cancer Research UK, the Rosetrees Trust, the JP Moulton foundation, Accuray and Elekta. Her current research interests include technical radiotherapy improvements in localised prostate cancer, oligometastatic and oligoprogressive disease.
Bertrand Tombal
Professor Bertrand Tombal is Chairman of the Department of Surgery and Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. Professor Tombal is a member of the Royal Academy of Medicine of Belgium. He has both a basic science and a clinical interest in urological oncology, particularly in the field of prostate and bladder cancer.